The opposite was observed by Kalbhen et al., who noted an impaired binding of vWF to platelets from COVID-19 patients after incubation with ristocetin; they also noted substantially higher vWF antigen concentration (vWF:Ag) than the normal range and elevated vWF collagen binding capacity (vWF:CB) [74]. The gene discussed is VWF; the disease is COVID-19.